Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lissa Hooi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Science Translational Medicine|August 10, 2018
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, et al.
Bioengineering & Translational Medicine|January 23, 2023
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinomaDexter Kai Hao Thng, Tan Boon Toh, Paolo Pigini, et al.
Biomaterials|April 28, 2022
Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironmentJoanne Tze Chin Lim, Leng Gek Kwang, Nicholas Ching Wei Ho, et al.
Npj Antimicrobials and Resistance|February 21, 2025
Flash optimization of drug combinations for Acinetobacter baumannii with IDentif.AI-AMRKui You, Nurhidayah Binte Mohamed Yazid, Li Ming Chong, et al.
Experimental Hematology & Oncology|June 2, 2020
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaXi Yun Zhang, Deepa Rajagopalan, Tae-Hoon Chung, et al.
Hepatology Communications|September 14, 2020
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma ProgressionYong Chun Chong, Tan Boon Toh, Zhiling Chan, et al.
Bioengineering & Translational Medicine|February 3, 2021
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug developmentAgata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah, et al.
NPJ Precision Oncology|February 27, 2024
A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoidsDexter Kai Hao Thng, Lissa Hooi, Bei En Siew, et al.
ACS Nano|August 17, 2022
IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 InterventionAgata Blasiak, Anh T L Truong, Peter Wang, et al.
Frontiers in Digital Health|June 18, 2026
Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AIPeter Wang, Kui You, Zi Wei Chia, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Science Translational Medicine|August 10, 2018
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, et al.
Bioengineering & Translational Medicine|January 23, 2023
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinomaDexter Kai Hao Thng, Tan Boon Toh, Paolo Pigini, et al.
Biomaterials|April 28, 2022
Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironmentJoanne Tze Chin Lim, Leng Gek Kwang, Nicholas Ching Wei Ho, et al.
Npj Antimicrobials and Resistance|February 21, 2025
Flash optimization of drug combinations for Acinetobacter baumannii with IDentif.AI-AMRKui You, Nurhidayah Binte Mohamed Yazid, Li Ming Chong, et al.
Experimental Hematology & Oncology|June 2, 2020
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaXi Yun Zhang, Deepa Rajagopalan, Tae-Hoon Chung, et al.
Hepatology Communications|September 14, 2020
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma ProgressionYong Chun Chong, Tan Boon Toh, Zhiling Chan, et al.
Bioengineering & Translational Medicine|February 3, 2021
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug developmentAgata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah, et al.
NPJ Precision Oncology|February 27, 2024
A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoidsDexter Kai Hao Thng, Lissa Hooi, Bei En Siew, et al.
ACS Nano|August 17, 2022
IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 InterventionAgata Blasiak, Anh T L Truong, Peter Wang, et al.
Frontiers in Digital Health|June 18, 2026
Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AIPeter Wang, Kui You, Zi Wei Chia, et al.
Pageof 3